84 matches for your search in the start-up spotlight
rss
Glox Therapeutics is developing a pipeline of engineered precision bacteriocins targeting pathogens that cause serious infections associated with high levels of antimicrobial resistance (AMR) and mortality. These novel precision antibiotics have potent narrow-spectrum activity to target ...
Orakl Oncology leverages tumor avatars that combine best-in-class biology with high-quality clinical and molecular data at scale. Our techbio platform enables oncology players to identify relevant targets and deliver better drugs, faster. As a spin-out from the Gustave Roussy Institute, the ...
Synfini, Inc., a privately held Menlo Park, California-based company, is a pioneer in agile chemistry. Its advanced, automated molecular discovery platform is transforming drug discovery through integrated neuro-symbolic AI, discovery-focused robotic automation, and world-class chemistry data. ...
BTRY is a start-up based in Dübendorf, Switzerland, and a spin-off of EMPA and ETH. From the lab to the market – at BTRY, we are developing the industry‘s first energy-dense solid-state battery made with advanced semiconductor manufacturing methods. Having worked together at EMPA and ETH Zurich ...
Mysthera Therapeutics AG was founded in Basel, Switzerland by Forty51 Ventures in 2023. Pursuing a first-in-class therapeutic approach, Mysthera plans to reshape the treatment landscape for autoimmune disease. PIM kinase inhibition uniquely and selectively modulates immune cell function in ...
Inhalis Therapeutics SA is committed to develop breakthrough inhaled treatments for life-threatening disorders. Solid science and industry-leading delivery technology are combined with an experienced management team to research and develop new inhaled treatments for Idiopathic Pulmonary Fibrosis ...
PhenomeX is empowering scientists to leverage the full potential of each cell and drive the next era of functional cell biology that will advance human health. We enable scientists to reveal the most complete insights on cell function and obtain a full view of the behavior of each cell. Our ...
Mallia Therapeutics GmbH is a biopharmaceutical company focused on developing novel treatments for patients suffering from hair loss. The Company was founded in 2023 in Erlangen, Germany, and is led by an experienced management team and worldwide leading experts in the field of CD83, with more ...
PHIOGEN INC was founded in 2023 to commercialize technology developed at TAILΦR Labs, a personalized phage therapy center of Baylor College of Medicine. PHIOGEN INC. is an innovative biotech company housed in the Texas Medical Center Innovation Hub. It is committed to using proven technology to ...
More and more entrepreneurs are recognizing the urgency of combating the climate crisis. You take responsibility by setting ambitious emissions targets for your business. With Path to Zero's digital tools, you reliably steer your company on the cost-optimal path to decarbonization.
